Clinical Trial Update: Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 2 study of docetaxel plus carboplatin in patients with stage IIIB or stage IV non-small cell lung cancer. The trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Hope Cancer Institute, Inc. | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN